GLPwatch
Ozempic vs Trulicity
Drug comparison
Last updated 2026-05-28 15:46 UTCOzempic (semaglutide, made by Novo Nordisk) and Trulicity (dulaglutide, made by Eli Lilly) are both injected under the skin to help manage type 2 diabetes and lower cardiovascular risk. The main differences are their active ingredients—semaglutide vs. dulaglutide—and their manufacturers, Novo Nordisk and Eli Lilly, respectively.
AI summary of the sources below.
| Ozempic | Trulicity | |
|---|---|---|
| Active ingredient | semaglutide | dulaglutide |
| Manufacturer | novo-nordisk | eli-lilly |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes, cardiovascular risk reduction, chronic kidney disease | type 2 diabetes, cardiovascular risk reduction |
| Label updated | 2026-01-30 | 2023-08-05 |